Burckhardt Compression (BCHN) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Burckhardt Compression CHF 625, price CHF 490, upside +27.7%, quality 68 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Burckhardt Compression for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range CHF 286.10 – CHF 707.12 · fair‑value band CHF 435.01 – CHF 845.55 · the CHF 489.50 price screens below the CHF 625.08 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Burckhardt Compression in your weekly email
Every Wednesday you see whether Burckhardt Compression is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Burckhardt Compression Holding AG manufactures and sells reciprocating compressor technologies worldwide.
Show more
Burckhardt Compression Holding AG manufactures and sells reciprocating compressor technologies worldwide. The company offers Laby, a labyrinth piston compressor that compresses bone-dry, dirty, abrasive, and other gases; Laby-GI compressors for offshore vessels and installations; process gas compressors per API 618 for high-pressure compression of hydrogen, hydrocarbons, and corrosive gases; hyper compressors, a high-pressure reciprocating compressor for low-density polyethylene and ethylene-vinyl acetate plants; diaphragm compressors for hydrogen fueling and trailer filling stations; fully balanced high-speed compressors for natural gas processing and transport applications; standard high-pressure compressors are used to compress air, hydrogen, nitrogen, helium, argon, natural gas, and other non-corrosive gases and gas mixtures at land facilities and on ships; and marine high-pressure compressors, as well as compressor systems and packages. It also provides various compressor components, such as valves, seals, packings, rings, capital and pump parts, and auxiliary equipment; and service solutions, including BC ACTIVATE holistic compressor assessment, preventive maintenance, overhauls and dry docks, comprehensive valve, repair, revamps and upgrades, turnaround, emission management, and installation and commissioning. In addition, the company offers digital solutions, such as UP! Insight, a fleet diagnostics and real-time monitoring; UP! Detect, a vibration monitoring for early failure detection; PROGNOST-NT, a condition monitoring; PROGNOST-SILver, a SIL3 machinery protection; and PROGNOST-Predictor for gearboxes and extruders, as well as provides technical support and training services. It provides compressor systems used in the petrochemical and chemical, gas transport and storage, hydrogen mobility and energy, refinery, industrial gas, and gas gathering and processing sectors. The company was founded in 1844 and is headquartered in Winterthur, Switzerland.
Stock analysis
Burckhardt Compression (BCHN) currently trades at CHF 489.50, while our model-based Fair Value estimate is CHF 625.08, implying the stock looks roughly 21.7% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of CHF 625.08 per share, and 17 of the 26 models we run sit above the CHF 489.50 price.
Bear case: the Asset-Based group reads lowest at CHF 71.77, and 9 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: CHF 435.01 (bear) to CHF 845.55 (bull), the price of CHF 489.50 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 68/100 (solid quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Burckhardt Compression reported revenue of CHF 1.1B in FY2026 versus CHF 651M in FY2022, a compound +12.9%/yr. Reported net income was CHF 110M in FY2026, compounding +21.7%/yr from FY2022.
Key figures
Market cap CHF 1.7B · P/E ratio 15.7 · P/S ratio 1.64 · EPS (TTM) CHF 31.12 · Dividend yield 3.7% · Net margin 10.4% · Return on equity 36.3% · Return on assets (EBIT) 10.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 18% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −49% fair-value upside, at 28%, BCHN screens cheaper than that median.
Fair Value models
Bear CHF 435.01Fair Value CHF 625.08Bull CHF 845.55
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (CHF 7.08 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.85/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−3.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.9%
Start year 2021 (pandemic). Over 10 years: +8.1% a year
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.1%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+23.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+20.2%
Dividend (yield on the price)3.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.20% vs 7%, picking up
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 14%
Start year 2021 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes less growth than the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+2.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+0.7%
Yearly sales growth analysts expect, extended to five years.
After inflation (Switzerland: IMF forecast 0.6% a year to 2030, 0.8% from 2016 to 2025) that is about +1.4% a year for the price and +0.1% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Industrial Machinery · 832 stocks
Beats the industry median on 10/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score68 · Top 25%
Fair Value upside+28% · Top 25%
Profitability
Return on equity (TTM)31% · Top 25%
Return on assets8% · Top 25%
Net margin (TTM)10% · Above median
Operating margin (TTM)15% · Top 25%
Growth and dividend
Revenue growth−9% · Bottom 25%
Dividend yield (TTM)3.7% · Top 25%
Balance sheet
Debt / equity0.42× · Highest 25%
Valuation Multiplesvs Specialty Industrial Machinery median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Burckhardt Compression Fair Value". https://www.fairvalue-calculator.com/stock/BCHN
Frequently asked questions
Is Burckhardt Compression (BCHN) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of CHF 625.08 versus a price of CHF 489.50, about +28% upside (undervalued).
What is the fair value of BCHN?
Our model-based fair value for Burckhardt Compression is CHF 625.08 (as of Sep 23, 2026), built from audited fundamentals. The current price: CHF 489.50.
What is the quality score of BCHN?
Burckhardt Compression has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Burckhardt Compression (BCHN)?
Our model-based price target is the fair value of CHF 625.08 (as of Sep 23, 2026) from 26 valuation models. Cautious scenario CHF 435.01, optimistic scenario CHF 845.55. It is a calculation from audited fundamentals, not an analyst target.
What is the Burckhardt Compression stock forecast for 2026?
Our models put fair value at CHF 625.08, about +28% upside versus a price of CHF 489.50 (undervalued). Cautious scenario CHF 435.01, optimistic scenario CHF 845.55. The calculation is refreshed regularly with new filings.
What is the revenue of Burckhardt Compression (BCHN)?
Burckhardt Compression reported trailing-twelve-month revenue of about CHF 1.1B (latest available figure, as of Sep 23, 2026).
Does Burckhardt Compression pay a dividend?
Burckhardt Compression currently shows a dividend yield of about 3.68% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Burckhardt Compression (BCHN)?
For today's price to be fair in a discounted-cash-flow model, Burckhardt Compression would have to grow free cash flow by +2.0 % per year for five years (discount rate 10.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.9 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of BCHN use?
Our models discount Burckhardt Compression at 10.4 %: a base by market capitalisation (small), damped by beta 0.79, country premium for Switzerland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Burckhardt Compression that is +2.0 % per year a year over ten years, using the same discount rate (10.4 %) and the same formula as our fair value.
How much growth has Burckhardt Compression (BCHN) delivered so far?
Over the past 5 years revenue at Burckhardt Compression grew +9.9 % a year. The price currently implies +2.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Burckhardt Compression (BCHN) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Burckhardt Compression (+2.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Burckhardt Compression (BCHN)?
The free-cash-flow yield on the price is 7.73 %: that much free cash flow Burckhardt Compression produces per unit of market value. When it exceeds the discount rate of our models (10.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Burckhardt Compression (BCHN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Burckhardt Compression it is CHF 625.08 per share (as of Sep 23, 2026), against a price of CHF 489.50. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Burckhardt Compression stock overvalued or undervalued in 2026?
As of Sep 23, 2026, BCHN trades below its calculated fair value: price CHF 489.50, fair value CHF 625.08, a gap of about +28% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BCHN?
No. The price is what the market pays today (CHF 489.50); the fair value is what the company's own numbers justify (CHF 625.08). For Burckhardt Compression the two are CHF 135.58 per share apart. That gap is exactly why we show both numbers side by side.
How much is Burckhardt Compression worth?
The market values Burckhardt Compression at about CHF 1.7B (market capitalisation, as of Sep 23, 2026). Per share that is CHF 489.50; our models calculate a fair value of CHF 625.08 per share.
What do the bullish and bearish scenarios say about BCHN?
Our models span a range for Burckhardt Compression: cautious scenario CHF 435.01, base CHF 625.08, optimistic CHF 845.55 per share (as of Sep 23, 2026, price CHF 489.50). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BCHN?
Burckhardt Compression trades at a price-to-earnings ratio of 15.7 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of CHF 625.08 is built from several models across several years. Other multiples: PEG 9.0, P/B 5.5, P/S 1.9, EV/EBITDA 11.2.
What is the PEG ratio of BCHN?
The PEG ratio of Burckhardt Compression is 9.03 (P/E divided by earnings growth, as of Sep 23, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Burckhardt Compression (BCHN)?
Balance-sheet figures for Burckhardt Compression (as of Sep 23, 2026): return on equity 31.4%, debt of 0.42 per unit of equity. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is BCHN from its 52-week high?
Burckhardt Compression trades at CHF 489.50, about 18% below its 52-week high of CHF 596.48 and 14% above the low of CHF 429.08 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of CHF 625.08 is for.
Which stocks are comparable to Burckhardt Compression?
From the same area (Industrials) we also value GE Vernova Inc, SIE, Eaton Corporation, Parker-Hannifin Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Burckhardt Compression stock attractive at the current price?
The data as of Sep 23, 2026: price CHF 489.50, calculated fair value CHF 625.08 (+28%), Quality Score 68/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BCHN calculated?
We run Burckhardt Compression through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of CHF 625.08, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Burckhardt Compression currently trades 28 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Burckhardt Compression (BCHN)?
The closing price on Sep 23, 2026 was CHF 489.50. Our model-based fair value is CHF 625.08, about +28% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Burckhardt Compression right now?
Solid quality (68/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (CHF 435.01 to CHF 845.55) leaves room in how you read the outcome.
Where does the earnings growth of Burckhardt Compression (BCHN) come from?
Earnings per share at Burckhardt Compression grew +8.2 % a year from 2015 to 2026. Broken into its drivers: revenue per share +8.4 %, EBIT margin −0.1 %, tax rate +0.0 %, residual (interest, one-offs) −0.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Burckhardt Compression
How large is the market capitalisation of Burckhardt Compression (BCHN)?
The market capitalisation of Burckhardt Compression is CHF 1.7B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Burckhardt Compression (BCHN)?
The price-to-sales ratio of Burckhardt Compression is 1.64 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Burckhardt Compression (BCHN)?
Earnings per share at Burckhardt Compression are CHF 31.12 (price ÷ EPS = P/E 15.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Burckhardt Compression (BCHN)?
The dividend yield of Burckhardt Compression is 3.7% (payout 57.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Burckhardt Compression (BCHN)?
The net margin of Burckhardt Compression is 10.4% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Burckhardt Compression (BCHN)?
The return on equity (ROE) of Burckhardt Compression is 36.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Burckhardt Compression (BCHN)?
On an EBIT basis the return on assets of Burckhardt Compression is 10.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Burckhardt Compression (BCHN)?
The operating margin of Burckhardt Compression is 12.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Burckhardt Compression (BCHN)?
Revenue at Burckhardt Compression is growing +2.8% versus a year earlier (3y avg +8.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Burckhardt Compression (BCHN)?
Earnings per share at Burckhardt Compression are growing −0.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Burckhardt Compression (BCHN) hold?
Burckhardt Compression holds more cash than debt, CHF 111M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Burckhardt Compression in the live analysis
One click puts Burckhardt Compression on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
